- Home
- PYPD vs WAI Comparison
PYPD vs WAI Comparison
Compare PYPD & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- WAI
- Stock Information
- Founded
- PYPD 2008
- WAI 2018
- Country
- PYPD Israel
- WAI China
- Employees
- PYPD N/A
- WAI N/A
- Industry
- PYPD Medical/Dental Instruments
- WAI
- Sector
- PYPD Health Care
- WAI
- Exchange
- PYPD Nasdaq
- WAI NYSE
- Market Cap
- PYPD 36.0M
- WAI 33.5M
- IPO Year
- PYPD 2020
- WAI 2023
- Fundamental
- Price
- PYPD $3.50
- WAI $3.66
- Analyst Decision
- PYPD Strong Buy
- WAI
- Analyst Count
- PYPD 5
- WAI 0
- Target Price
- PYPD $11.40
- WAI N/A
- AVG Volume (30 Days)
- PYPD 1.4M
- WAI 966.6K
- Earning Date
- PYPD 08-13-2025
- WAI 08-24-2025
- Dividend Yield
- PYPD N/A
- WAI N/A
- EPS Growth
- PYPD N/A
- WAI N/A
- EPS
- PYPD N/A
- WAI N/A
- Revenue
- PYPD N/A
- WAI $3,750,352.00
- Revenue This Year
- PYPD N/A
- WAI N/A
- Revenue Next Year
- PYPD N/A
- WAI N/A
- P/E Ratio
- PYPD N/A
- WAI N/A
- Revenue Growth
- PYPD N/A
- WAI N/A
- 52 Week Low
- PYPD $2.30
- WAI $1.38
- 52 Week High
- PYPD $4.42
- WAI $20.00
- Technical
- Relative Strength Index (RSI)
- PYPD 56.01
- WAI N/A
- Support Level
- PYPD $3.42
- WAI N/A
- Resistance Level
- PYPD $3.62
- WAI N/A
- Average True Range (ATR)
- PYPD 0.18
- WAI 0.00
- MACD
- PYPD -0.03
- WAI 0.00
- Stochastic Oscillator
- PYPD 60.51
- WAI 0.00
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).